SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab buys 70% in biotech start-up Inbiopro

10 Dec 2010 Evaluate

Strides Arcolab announced its entry into biologics, with the signing of an agreement to acquire 70 per cent stake in biotechnology company Inbiopro Solutions, based in Bangalore.

Inbiopro is a biotech outsourced research start-up and has eight candidate products in oncology to begin with. Strides will invest Rs 65 crore over three years in the form of growth capital to develop and commercialise the eight products. The acquisition gives Strides immediate access to a pipeline of eight products estimated to have global sales of over $28 billion. Commercialisation of these products is expected to begin in 2013.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×